
Predictive Genetic Counselling Market Report 2026
Global Outlook – By Service Type (Risk Assessment, Carrier Testing, Predictive Testing, Other Service Types), By Mode Of Delivery (In-Person, Online), By Application (Consumer Genomics, Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Applications), By End-User (Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Predictive Genetic Counselling Market Overview
• Predictive Genetic Counselling market size has reached to $4.19 billion in 2025 • Expected to grow to $8.79 billion in 2030 at a compound annual growth rate (CAGR) of 15.9% • Growth Driver: Growing Prevalence Of Genetic Disorders Fueling The Growth Of The Market Due To Increasing Demand For Early Risk Assessment • Market Trend: Advancements In Predictive Genetic Testing Service To Enhanced Risk Detection, Personalized Care, And Clinical Decision Support • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Predictive Genetic Counselling Market?
Predictive genetic counselling is a process that determines an individual’s risk of developing or passing on genetic disorders, often before symptoms appear. It involves evaluating genetic test results, studying family history, and explaining potential health implications. Its purpose is to enable informed decisions about healthcare, lifestyle, and reproduction, promote early disease prevention, and offer emotional support in managing genetic risk information. The main service types of predictive genetic counseling are risk assessment, carrier testing, predictive testing, and others. Risk assessment service gathers personal and family health histories, existing genetic test results, and factors like ethnicity to estimate someone’s chances of developing a genetic disorder. It includes various predictive tests, such as genetic susceptibility tests, predictive diagnostics, and population screening, and is delivered through multiple modes, including in-person and online. It is applied in several applications, including consumer genomics, breast and ovarian cancer, cardiovascular screening, diabetic screening and monitoring, colon cancer, parkinsonism or Alzheimer’s disease, urologic screening or prostate cancer screening, orthopedic and musculoskeletal, and others, and is used by several end-users, including hospitals and clinics, diagnostic laboratories, research and academic institutes, and others.
What Is The Predictive Genetic Counselling Market Size and Share 2026?
The predictive genetic counselling market size has grown rapidly in recent years. It will grow from $4.19 billion in 2025 to $4.87 billion in 2026 at a compound annual growth rate (CAGR) of 16.2%. The growth in the historic period can be attributed to increasing utilization of family history evaluation, expansion of cancer risk screening programs, growing acceptance of genetic testing, improvements in counseling methodologies, rising public awareness of inherited diseases.What Is The Predictive Genetic Counselling Market Growth Forecast?
The predictive genetic counselling market size is expected to see rapid growth in the next few years. It will grow to $8.79 billion in 2030 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to increasing integration of genomics into routine healthcare, rising adoption of virtual counseling platforms, expansion of preventive screening initiatives, growing use of ai-based genetic interpretation, increasing demand for personalized health risk insights. Major trends in the forecast period include increasing demand for online genetic counseling services, rising use of polygenic risk scoring, growing adoption of direct-to-consumer genetic testing, expansion of predictive oncology counseling, enhanced focus on patient education and decision support.Global Predictive Genetic Counselling Market Segmentation
1) By Service Type: Risk Assessment, Carrier Testing, Predictive Testing, Other Service Types 2) By Mode Of Delivery: In-Person, Online 3) By Application: Consumer Genomics, Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Applications 4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users Subsegments: 1) By Risk Assessment: Family History Evaluation, Lifestyle And Environmental Risk Analysis, Polygenic Risk Score Analysis, Hereditary Disease Susceptibility Screening 2) By Carrier Testing: Cystic Fibrosis Carrier Testing, Tay-Sachs Carrier Testing, Fragile X Syndrome Testing, Sickle Cell Carrier Testing, Thalassemia Carrier Screening 3) By Predictive Testing: Breast Cancer Gene 1 (BRCA1) Or Breast Cancer Gene 2 (BRCA2) Mutation Testing, Lynch Syndrome Testing, Huntington’s Disease Testing, Cardiovascular Genetic Risk Testing, Neurological Disorder Prediction Testing 4) By Other Service Types: Pharmacogenomic Testing, Prenatal Genetic Testing, Newborn Genetic Screening, Direct-To-Consumer Genetic Testing, Whole Genome Sequencing For PredictionWhat Is The Driver Of The Predictive Genetic Counselling Market?
The growing prevalence of genetic disorders is expected to propel the growth of the predictive genetic counselling market going forward. Genetic disorders are conditions that result from changes or defects in a person’s DNA, impacting the body’s growth, development, and overall function. The rise in genetic disorders is due to increasing parental age, as older age at conception is linked to a higher likelihood of genetic mutations in offspring. Genetic disorders support the growth of predictive genetic counselling by increasing the demand for risk assessment services that help individuals understand their likelihood of inheriting or passing on such conditions. For instance, in October 2024, according to the Cystic Fibrosis Trust, a UK-based charitable organization, the number of patients registered with cystic fibrosis rose to 11,318 in 2023, up from 11,148 in 2022. Therefore, the growing prevalence of genetic disorders is driving the predictive genetic counselling industry.Key Players In The Global Predictive Genetic Counselling Market
Major companies operating in the predictive genetic counselling market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Natera Inc, Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, 23andMe Holding Co, Color Genomics Inc, deCODE genetics, Centogene NV, Admera Health LLC, Mapmygenome, Exact Sciences Corporation, BGI GroupGlobal Predictive Genetic Counselling Market Trends and Insights
Major companies operating in the predictive genetic counselling market are focusing on developing advanced solutions such as the predictive genetic testing service for early disease risk detection and support for informed clinical decision-making. Predictive genetic testing service refers to a medical service that analyzes an individual's DNA to identify genetic variations associated with an increased risk of developing specific inherited conditions or diseases in the future. For instance, in August 2024, Genetic Technologies Limited, an Australia-based company that provides genomics-based health testing, launched the geneType Risk Assessment test. This test is a unique, comprehensive, multi-risk predictive genetic screening tool designed to assess an individual’s likelihood of developing serious conditions such as breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease, and type 2 diabetes. It combines clinically validated polygenic risk scores with non-genetic factors such as age, family history, and clinical measurements to deliver a personalized, actionable risk profile. It is designed for proactive health management and also provides clear reports with tailored recommendations to guide preventive care and lifestyle choices in over 42 countries.What Are Latest Mergers And Acquisitions In The Predictive Genetic Counselling Market?
In February 2025, Tempus AI, Inc., a US-based provider of AI-enabled precision medicine and diagnostic solutions, acquired Ambry Genetics for a total consideration of USD 600 million. With this acquisition, Tempus AI gains access to Ambry’s established genetic-testing infrastructure, variant-interpretation expertise, and comprehensive hereditary-risk testing portfolio, thereby expanding its capabilities in genomic diagnostics while improving operational scale, clinical-testing reach, and service delivery. Ambry Genetics is a US-based provider of genetic-testing services, known for its specialization in hereditary cancer screening, rare-disease testing, and advanced variant interpretation.Regional Outlook
North America was the largest region in the predictive genetic counselling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Predictive Genetic Counselling Market?
The predictive genetic counselling market includes revenues earned by entities through the pharmacogenomic testing, prenatal testing, newborn screening, and lifestyle or prevention planning. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Predictive Genetic Counselling Market Report 2026?
The predictive genetic counselling market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the predictive genetic counselling industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Predictive Genetic Counselling Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.87 billion |
| Revenue Forecast In 2035 | $8.79 billion |
| Growth Rate | CAGR of 16.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Service Type, Mode Of Delivery, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Natera Inc, Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, 23andMe Holding Co, Color Genomics Inc, deCODE genetics, Centogene NV, Admera Health LLC, Mapmygenome, Exact Sciences Corporation, BGI Group |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
